NDC 44087-4000
Mavenclad
Cladribine
Mavenclad is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Cladribine.
| Product ID | 44087-4000_673d345e-01f3-4692-b223-5f2199c1d78d |
| NDC | 44087-4000 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mavenclad |
| Generic Name | Cladribine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-04-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022561 |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | CLADRIBINE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Purine Antimetabolite [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 44087-4000-0
5 BLISTER PACK in 1 CARTON (44087-4000-0) > 2 TABLET in 1 BLISTER PACK
| Marketing Start Date | 2019-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 44087-4000-5 [44087400005]
Mavenclad TABLET
| Marketing Category | NDA |
| Application Number | NDA022561 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-01 |
NDC 44087-4000-9 [44087400009]
Mavenclad TABLET
| Marketing Category | NDA |
| Application Number | NDA022561 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-01 |
NDC 44087-4000-7 [44087400007]
Mavenclad TABLET
| Marketing Category | NDA |
| Application Number | NDA022561 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-01 |
NDC 44087-4000-6 [44087400006]
Mavenclad TABLET
| Marketing Category | NDA |
| Application Number | NDA022561 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-01 |
NDC 44087-4000-4 [44087400004]
Mavenclad TABLET
| Marketing Category | NDA |
| Application Number | NDA022561 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-01 |
NDC 44087-4000-0 [44087400000]
Mavenclad TABLET
| Marketing Category | NDA |
| Application Number | NDA022561 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-01 |
NDC 44087-4000-8 [44087400008]
Mavenclad TABLET
| Marketing Category | NDA |
| Application Number | NDA022561 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CLADRIBINE | 10 mg/1 |
OpenFDA Data
| SPL SET ID: | 9c75e30a-a410-40f1-b653-04d532bd9144 |
| Manufacturer | |
| UNII |
Pharmacological Class
- Purine Antimetabolite [EPC]
- Purine Antimetabolite [EPC]
NDC Crossover Matching brand name "Mavenclad" or generic name "Cladribine"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 44087-4000 | Mavenclad | Cladribine |
| 0143-9871 | Cladribine | Cladribine |
| 42658-010 | Cladribine | Cladribine |
| 63323-140 | Cladribine | CLADRIBINE |
| 67457-450 | Cladribine | Cladribine |
Trademark Results [Mavenclad]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MAVENCLAD 79214141 5393708 Live/Registered |
Merck KGaA 2017-05-19 |
 MAVENCLAD 79202778 5253420 Live/Registered |
Merck KGaA 2017-01-18 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.